TATAINVEST Q3 FY24 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹51 Cr
verified against source
Revenue YoY
9.4%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Tata Elxsi reported Q3 FY24 revenue of INR 914.2 crores, up 9.4% YoY in constant currency terms, with EBITDA margin sustained at 29.5%. The transportation vertical (84.7% of revenue) saw 1.9% QoQ growth but faced customer-side delays in deal ramp-ups, while the media & communication vertical remained under stress with no green shoots visible. Healthcare delivered a strong 3.9% QoQ recovery on large new deal wins. Management invested ahead of revenue—employee costs rose to 54.5% of revenue (vs 50.5% YoY)—with 350 net hires in Q3 and ~40 bps AI-related investments. U.S. OEM business remains selectively avoided due to unfavorable terms, with growth led by Europe (+5% QoQ) and recovering APAC. Management is cautious on media, hopeful on healthcare reaching 20% of revenues by FY26, and expects Q4 transportation ramp-ups to close the execution gap. Key risks include persistent M&C weakness, Tier 1 headwinds from OEM verticalization, and margin pressure from high bench costs.
Colored figures show movement against the previous available record.
Guidance to track
- Management confirmed they are on track to reach this target, driven by new product development and digital healthcare opportunities, with the team having successfully retargeted skills from MDR to other regulatory areas.
- Several large deals won in Q2 with planned Q3 ramp-ups were delayed due to customer-side issues (union problems, shorter quarter/holidays); management is ready with resources and expects these to accelerate into Q4.
- The company is ramping up investments in AI infrastructure, talent, and training in the coming quarters, expanding applications across product lifecycles and domains, as demonstrated by AI being embedded in recent deal wins (media consolidation and healthcare automation).
Risks flagged
- Analyst Sulabh Govila pressed management on whether H2 would outperform H1 given their prior guidance; management acknowledged the aspiration is at risk as media recovery has not materialized as hoped, making Q4 recovery targets steeper.
- Analyst Bhavik Mehta asked what is driving price competitiveness from U.S. OEMs; management revealed that some competitors are accepting unlimited liability clauses that Tata Elxsi will not accept, limiting deal participation in a key geography.
- Management was cautious despite strong Q3 performance, asking for one more quarter of data to confirm the growth recovery is durable rather than a temporary uptick before providing confident forward guidance.
- Shareholder Ravi Naredi asked about order book (multi-quarter visibility typical in software services); management declined to share details, making it difficult to independently verify the strength of the claimed pipeline vs. actual revenue conversion.
Key quotes
- We continue to invest in our talent and get ready to execute those programs, as seen in the sort of strong hiring that is ongoing. So it's a question of some of these deals, the start of these deals or some of the ramp ups of these deals getting pushed a little bit here and there, again, due to customer-related issues.
- The consolidation part is where we are saying, look, instead of working with many, many suppliers, which for us the universe is open because of our capabilities, we are taking selective bets on a few. And what we want to do is to make sure that we grow very well and very sustainably with those few.
- We are one of the few companies that are adding headcount at this point in time. So I think we'll be a little cautious this quarter and the next quarter in terms of... we have a healthy bench, so there is no need to keep adding resources. I think we've reached a point where we have planned for all the orders that we have won.
Research modules